Stock Events

Globus Medical 

$71.07
72
+$0.32+0.45% Friday 20:00

統計

當日最高
71.23
當日最低
70.39
52週最高
71.23
52週最低
43.39
成交量
608,621
平均成交量
928,777
市值
8B
市盈率
131.13
股息收益率
-
股息
-

收益

7May確認
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0.5
0.57
0.65
0.72
預期每股收益
0.57
實際每股收益
0.72

人們還關注

此列表基於在 Stock Events 上關注 GMED 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

73.4$平均價格目標
最高估價為 $85。
來自過去 6 個月內的 6 個評級。這不是投資建議。
買入
67%
持有
33%
賣出
0%

關於

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Show more...
首席執行官
David Demski
員工
5000
國家
US
ISIN
US3795772082
WKN
000A1J2LY

上市公司